newsfilter
← Latest News
Business Wire·

BELLUS Health Reports Third Quarter 2022 Financial Results and Business Highlights

- Initiated CALM Phase 3 program with topline data expected for CALM-1 and CALM-2 in the second half of 2024 and 2025, respectively - - Ended third quarter 2022 with US$364.4 million in cash, cash equivalents and